ArticleAmerican journal of clinical dermatology2024
Switching to Interleukin-23 Inhibitors After Ineffectiveness of Ustekinumab: Evaluating Real-World Outcomes in Psoriasis Treatment.
Sarah E Thomas et al.PubMed ↗Publisher ↗
No numbers read from the abstract.